Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Operational Highlights
DVA logo

DaVita's Q3 Revenues Rise 1.2% to $3.42B Amid Volume Pressures

DVA10-QFiling Date: 10/29/2025
DaVita Inc.
Description

What this story covers

DaVita Inc.'s Q3 2025 10-Q shows $3.42B revenue, up 1.2% sequentially, driven by U.S. dialysis growth but offset by ancillary declines and higher costs. Net income fell to $150M amid debt expenses; liquidity remains strong at $2.21B, supporting expansions and repurchases.

Story snapshot

CompanyDaVita Inc.
TickerDVA
VariantStandard detailed
Duration14:19
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0000927066-25-000165

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in